Skip to content

RLAY

Relay Therapeutics, Inc.

NASDAQ · USHealthcareBiotechnology
$19.18-3.67%

Price as of Jul 20, 2026

RLAY analysis

Relay Therapeutics, Inc. stock analysis

Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.

Analysis for RLAY is not published yet

Browse the public research library while company-specific analysis is being prepared. Explore research